A phase II study of high-dose cisplatin, vinblastine, bleomycin, and etoposide (PVeBV regimen) in malignant nondysgerminomatous germ-cell tumors of the ovary.

Source:http://linkedlifedata.com/resource/pubmed/id/7517380

Download in:

View as

General Info

PMID
7517380